Abstract
The mechanics of blood flow with clot formation, growth, and dissolution is affected by the biochemical reactions underlying clot formation, growth, and dissolution. A framework of models combining the biochemistry and mechanics of the phenomenon should include a model for the biochemistry underlying the same. A mathematical model to describe the biochemical changes underlying the formation, growth and dissolution of clots in vitro has been developed in Anand et al. (J Theor Biol 253(4):725–738, 2008). In this paper, the model is extended to include the equations for the intrinsic pathway thereby addressing a shortcoming of the previous model. The effect of the intrinsic pathway on clot formation, growth and dissolution in quiescent plasma, as well as the effect on the impact of ATIII and Protein C deficiencies on clot growth parameters is documented. The inclusion of the intrinsic pathway leads to faster appearance of the clot, and a larger clot. The intrinsic pathway has minimal impact on the effects of ATIII and Protein C deficiencies.
Similar content being viewed by others
References
Ahmad, S.S., Rawalasheikh, R., Walsh, P.N.: Comparative interactions of factor-IX and factor-IXa with human platelets. J. Biol. Chem. 264(6), 3244–3251 (1989)
Anand, M., Rajagopal, K., Rajagopal, K.R.: A model incorporating some of the mechanical and biochemical factors underlying clot formation and dissolution in flowing blood. J. Theor. Med. 5(3–4), 183–218 (2003)
Anand, M., Rajagopal, K., Rajagopal, K.R.: A model for the formation, growth, and lysis of clots in quiescent plasma. A comparison between the effects of antithrombin III deficiency and protein C deficiency. J. Theor. Biol. 253(4), 725–738 (2008)
Bergel, D.H.: The dynamic elastic properties of the arterial wall. J. Physiol. 156, 458–469 (1961)
Bodnar, T., Sequeira, A.: Numerical simulation of the coagulation dynamics of blood. Comput. Math. Method Med. 9(2), 83–104 (2008)
Booth, N.A.: Fibrinolysis and thrombosis. Baillière Clin. Haem. 12(3), 423–433 (1999)
Bridges, C., Rajagopal, K.R.: Pulsatile flow of a chemically-reacting nonlinear fluid. Comput. Math. Appl. 52(6–7), 1131–1144 (2006)
Brummel-Ziedins, K., Orfeo, T., Jenny, N.S., Everse, S.J., Mann, K.G.: Blood coagulation and fibrinolysis. In: Wintrobe’s Hematology, 11th edn. Lippncott, Williams, and Wilkins, Philadelphia (2004)
Bungay, S.D., Gentry, P.A., Gentry, R.D.: A mathematical model of lipid-mediated thrombin generation. Math. Med. Biol. 20, 105–129 (2003)
Butenas, S., Mann, K.G.: Blood coagulation. Biochemistry (Moscow) 67(1), 3–12 (2002)
Chien, S., Usami, S., Dellenback, R.J., Gregersen, M.I.: Blood viscosity: influence of erythrocyte aggregation. Science 157(3790), 829–831 (1967)
Chien, S., Usami, S., Dellenback, R.J., Gregersen, M.I.: Blood viscosity: influence of erythrocyte deformation. Science 157(3790), 827–829 (1967)
Colman, R.W., Clowes, A.W., George, J.N., Hirsh, J., Marder, V.J.: Overview of hemostasis. In: Colman, R.W., Hirsh, J., Marder, V.J., Clowes, A.W., George, J.N. (eds) Hemostasis and Thrombosis, 4th edition., pp. 1–16. Lippincott, Williams and Wilkins (2001)
Danforth, C.M., Orfeo, T., Mann, K.G., Brummel-Ziedins, K.E., Everse, S.J.: The impact of uncertainty in a blood coagulation model. Math. Med. Biol. 26(4), 323–336 (2009)
Davie, E.W., Ratnoff, O.D.: Waterfall sequence for intrinsic blood clotting. Science 145, 1310–1311 (1964)
De Cristofaro, R., De Filippis, V.: Interaction of the 268–282 region of glycoprotein Ib alpha with the heparin-binding site of thrombin inhibits the enzyme activation of factor VIII. Biochem. J. 373(2), 593–601 (2003)
Diamond, S.L., Anand, S.: Inner clot diffusion and permeation during fibrinolysis. Biophys. J. 65, 2622–2643 (1993)
Ferry, J.D., Morrison, P.R.: Preparation and properties of serum and plasma proteins. VIII. The conversion of human fibrinogen to fibrin under various conditions. J. Am. Chem. Soc. 69, 388–400 (1947)
Freyssinet, J.M., Orfanoudakis, F.T., Ravanat, C., Grunebaum, L., Gauchy, J., Cazenave, J.P., Wiesel, M.L.: The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma. Blood. Coagul. Fibrin. 2, 691–698 (1991)
Gailani, D., Broze, G.J.: Factor XI activation in a revised model of blood coagulation. Science 253(5022), 909–912 (1991)
Heeb, M.J., Bischoff, R., Courtney, M., Griffin, J.H.: Inhibition of activated protein C by recombinant α1-antitrypsin variants with substitution of arginine or leucine for methionine. J. Biol. Chem. 265(4), 2365–2389 (1990)
Kalafatis, M., Egan, J.O., vant Veer, C., Cawthern, K.M., Mann, K.G.: The regulation of clotting factors. Crit. Rev. Eukar. Gene 7(3), 241–280 (1997)
Kaplan, K.L., Mather, T., DeMarco, L., Solomon, S.: Effect of fibrin on endothelial cell production of prostacyclin and tissue plasminogen activator. Arteriosclerosis 9(1), 43–49 (1989)
Karsan, A.L., Harlan, J.M.: The blood vessel wall. In: Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E., McGlave, P. (eds) Hematology: Basic Principles and Practice, 3rd edn., pp. 1770–1782. Churchill Livingstone, New York (2000)
Kolev, K., L, C., Lerant, I., Tenekkejiev, K., Machovich, R.: Regulation of fibrinolytic activity of neutrophil leukocyte elastase, plasmin, and miniplasmin by plasma protease inhibitors. J. Biol. Chem. 269(25), 17030–17034 (1994)
Kolev, K., Longstaff, C., Machovich, R.: Fibrinolysis at the fluid–solid interface of thrombi. J. Biol. Chem. 3(4), 341–355 (2005)
Kolev, K., Machovich, R.: Molecular and cellular modulation of fibrinolysis. Thromb. Haemost. 89(4), 610 (2003)
Komiyama, Y., L, C., Lerant, I., Tenekkejiev, K., Machovich, R.: Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor. Biochemistry (US) 29(40), 9418–9425 (1990)
Krishnaswamy, S., Church, W.R., Nesheim, M.E., Mann, K.G.: Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism. J. Biol. Chem. 262(7), 3291–3299 (1987)
Kuharsky, A., Fogelson, A.F.: Surface mediated control of blood coagulation: the role of binding site densities and platelet deposition. Biophys. J. 80, 1050–1094 (2001)
Levin, E.G., Marzec, U., Anderson, J., Harker, L.A.: Thrombin stimulates tissue plasminogen activator release from cultured human endothelial cells. J. Clin. Invest. 74, 1988–1995 (1984)
Levine, S.N.: Enzyme amplifier kinetics. Science 152, 651–653 (1966)
Lijnen, H.R., Collen, D.: Molecular and cellular basis of fibrinolysis. In: Hoffman, R., Benz, E.J., Shattil, S.J., Furie, B., Cohen, H.J., Silberstein, L.E., McGlave, P. (eds) Hematology: Basic Principles and Practice, 3rd edn., pp. 1804–1814. Churchill Livingstone, New York (2000)
Luan, D., Zai, M., Varner, J.D.: Computationally derived points of fragility of a human cascase are consistent with current therapeutic strategies. PLOS Comput. Biol. 3(7), e142 (2007)
MacFarlane, R.G.: An enzyme cascade model in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202, 498–499 (1964)
Madison, E.L., Coombs, G.S., Corey, D.R.: Substrate-specificity of tissue-type plasminogen-activator—characterization of the fibrin-dependent specificity of t-PA for plasminogen. J. Biol. Chem. 270(13), 7558–7562 (1995)
Mann, K.G.: The assembly of blood clotting complexes on membranes. Trends Biochem. Sci. 12(6), 229–233 (1987)
Mann, K.G., Brummel-Ziedins, K., Orfeo, T., Butenas, S.: Models of blood coagulation. Blood Cell. Mol. Dis. 36, 108–117 (2006)
Mann, K.G., Gaffney, D., Bovill, E.G.: Molecular biology, biochemistry, and lifespan of plasma coagulation factors. In: Beutler, E. (ed) Williams Hematology, 5th edn., pp. 1206–1226. McGraw Hill Inc., New York (1995)
Meijers, J.C.M., Vlooswijk, R.A.A., Bouma, B.N.: Inhibition of human blood coagulation factor XIa byC1-inhibitor. Biochemistry 27(12), 959–963 (1988)
Monkovic, D.D., Tracy, P.B.: Functional characterization of human platelet-released factor V and its activation by factor Xa and thrombin. J. Biol. Chem. 265(28), 17132–17140 (1990)
Nesheim, M.E., Tracy, R.P., Mann, K.G.: “Clotspeed,” a mathematical simulation of the functional properties of prothrombinase. J. Biol. Chem. 259(3), 1447–1453 (1984)
Neuenschwander, P.F., Jesty, J.: Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate. Arch. Biochem. Biophys. 296(2), 426–434 (1992)
Orfeo, T., Butenas, S., Brummel-Ziedins, K.E., Mann, K.G.: The tissue factor requirement in blood coagulation. J. Biol. Chem. 280(52), 42887–42896 (2005)
Ovanesov, M.V., Krasotkina, J.V., Ulyanova, L.I., Abushinova, K.V., Plyushch, O.P., Domogatskii, S.P., Vorobev, A.I., Ataullakhanov, F.I.: Hemophilia a and b are associated with abnormal spatial dynamics of clot growth. BBA Gen. Subj. 1572(1), 45–57 (2002)
Panteleev, M.A., Ovanesov, M.V., Kireev, D.A., Shibeko, A.M., Sinauridze, E.I., Ananyeva, N.M., Butylin, A.A., Saenko, E.L., Ataullakhanov, F.I.: Spatial propagation and localization of blood coagulation are regulated by intrinsic and protein C pathways, respectively. Biophys. J. 90(5), 1489–1500 (2006)
Perktold, K., Rappitsch, G.: Computer simulation of local blood flow and vessel mechanics in a compliant carotid artery bifurcation model. J. Biomech. 28(7), 845–856 (1995)
Pixley, R.A., Schapira, M., Colman, R.W.: The regulation of human factor XIIa by plasma proteinase inhibitors. J. Biol. Chem. 260(3), 1723–1729 (1985)
Rawalasheikh, R., Ahmed, S.S., Ashby, B., Walsh, P.N.: Kinetics of coagulation factor X activation by platelet-bound factor IXa. Biochemistry (US) 29(10), 2606–2611 (1990)
Schousboe, I., Feddersen, K., Rojkjaer, R.: Factor XIIa is a kinetically favorable plasminogen activator. Thromb. Haemost. 82, (1999)
Schrauwen, Y., Kooistra, T., de Vries, R.E.M., Emeis, J.J.: Studies on the acute release of tissue-type plasminogen activator from human endothelial cells in vitro and in rats in vivo: evidence for a dynamic storage pool. Blood 85(12), 3510–3517 (1995)
Scott, C.F., Schapira, M., James, H.L., Cohen, A.B., Colman, R.W.: Inactivation of factor XIa by plasma protease inhibitors. J. Clin. Invest. 69(12), 844–852 (1982)
Silverberg, M., Kaplan, A.P.: Enzymatic activities of activated and zymogen forms of human hageman factor (factor XII). Blood 60(1), 64–70 (1982)
Solymoss, S., Tucker, M.M., Tracy, P.B.: Kinetics of inactivation of membrane-bound factor Va by activated protein C. J. Biol. Chem. 263(29), 14884–14890 (1988)
Soons, H., Janssen-Claessen, T., Tans, G., Hemker, H.C.: Inhibition of factor XIa by antithrombin III. Biochemistry (US) 26(15), 4624–4629 (1987)
Sun, Y., Gailani, D.: Identification of a factor IX binding site on the third apple domain of activated factor XI. J. Biol. Chem. 271(46), 29023–29028 (1996)
Tankersly, D.L., Finlayson, J.S.: Kinetics of activation and auto-activation of human factor XII. Biochem 23, (1984)
Thurston, G.B.: The viscoelasticity of blood. Biophys. J. 21(2), 1205–1217 (1972)
Tsiang, M., Paborsky, L.R., Li, W.X., Jain, A.K., Mao, C.T., Dunn, K.E., Lee, D.W., Matsumura, S.Y., Matteucci, M.D., Coutre, S.E., Leung, L.L.K., Gibbs, C.S.: Protein engineering thrombin for optimal specificity and potency of anticoagulant activity in vivo. Biochemistry (US) 35, 16449–16457 (1996)
Van der Graaf, F., Koedam, J.A., Bouma, B.N.: Inactivation of kallikrein in human plasma. J. Clin. Invest. 71(1), 149–158 (1983)
Virchow, R.: Über den faserstoff : V. phlogose und thrombose im gefäßsystem. In: Gesammelte Abhandlungen zur wissenschaftlichen Medicin, 1st edn. Verlag v. Meidinger, Sohn and Corp., Frankfurt am Main (1856)
Wiebe, E.M., Stafford, A.R., Fredenburgh, J.C., Weitz, J.I.: Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide. J. Biol. Chem. 278(37), 35767–35774 (2003)
Young, M.E., Carroad, P.A., Bell, R.L.: Estimation of diffusion coefficients of proteins. Biotechnol. Bioeng. 22, 947–955 (1980)
Zarnitsina, V.I., Pokhilko, A.V., Ataullakhanov, F.I.: A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. I. The model description. Thromb. Res. 84(4), 225–236 (1996)
Zarnitsina, V.I., Pokhilko, A.V., Ataullakhanov, F.I.: A mathematical model for the spatio-temporal dynamics of intrinsic pathway of blood coagulation. II. Results. Thromb. Res. 84(5), 333–344 (1996)
Acknowledgements
DEL was supported from Professor K. R. Rajagopal’s endowment as a professor, and from an NSF grant: this support is gratefully acknowledged. MA thanks Kaminee Anand for drawing a major part of Fig. 1.
Author information
Authors and Affiliations
Corresponding author
Additional information
Dedicated to Professor K. R. Rajagopal on his 60th birthday
Rights and permissions
About this article
Cite this article
LaCroix, D.E., Anand, M. A model for the formation, growth, and dissolution of clots in vitro. Effect of the intrinsic pathway on antithrombin III deficiency and protein C deficiency. Int J Adv Eng Sci Appl Math 3, 93–105 (2011). https://doi.org/10.1007/s12572-011-0040-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12572-011-0040-0